Acadian Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154K | Buy |
7,128
+1,877
| +36% | +$40.6K | ﹤0.01% | 1347 |
|
|
2025
Q1 | $127K | Sell |
5,251
-15,296
| -74% | -$370K | ﹤0.01% | 1316 |
|
|
2024
Q4 | $428K | Buy |
+20,547
| New | +$428K | ﹤0.01% | 1107 |
|
|
2023
Q1 | – | Sell |
-30,153
| Closed | -$560K | – | 1772 |
|
|
2022
Q4 | $560K | Sell |
30,153
-860,904
| -97% | -$16M | ﹤0.01% | 1002 |
|
|
2022
Q3 | $11.4M | Sell |
891,057
-500,509
| -36% | -$6.42M | 0.06% | 244 |
|
|
2022
Q2 | $9.76M | Sell |
1,391,566
-130,143
| -9% | -$912K | 0.05% | 270 |
|
|
2022
Q1 | $12.6M | Buy |
1,521,709
+145,743
| +11% | +$1.21M | 0.05% | 276 |
|
|
2021
Q4 | $9.31M | Sell |
1,375,966
-58,984
| -4% | -$399K | 0.03% | 321 |
|
|
2021
Q3 | $7.6M | Buy |
1,434,950
+349,859
| +32% | +$1.85M | 0.03% | 360 |
|
|
2021
Q2 | $6.24M | Sell |
1,085,091
-119,587
| -10% | -$688K | 0.02% | 413 |
|
|
2021
Q1 | $5.55M | Buy |
1,204,678
+470,649
| +64% | +$2.17M | 0.02% | 447 |
|
|
2020
Q4 | $2.45M | Buy |
734,029
+35,702
| +5% | +$119K | 0.01% | 705 |
|
|
2020
Q3 | $2.07M | Sell |
698,327
-2,234
| -0.3% | -$6.63K | 0.01% | 658 |
|
|
2020
Q2 | $3.24M | Sell |
700,561
-163,586
| -19% | -$756K | 0.01% | 592 |
|
|
2020
Q1 | $3.33M | Buy |
864,147
+244,416
| +39% | +$941K | 0.02% | 471 |
|
|
2019
Q4 | $2.32M | Buy |
619,731
+400,629
| +183% | +$1.5M | 0.01% | 641 |
|
|
2019
Q3 | $1.16M | Buy |
219,102
+142,686
| +187% | +$757K | 0.01% | 849 |
|
|
2019
Q2 | $293K | Buy |
+76,416
| New | +$293K | ﹤0.01% | 1135 |
|
|
2018
Q4 | – | Sell |
-23,544
| Closed | -$89K | – | 1732 |
|
|
2018
Q3 | $89K | Sell |
23,544
-129,094
| -85% | -$488K | ﹤0.01% | 1233 |
|
|
2018
Q2 | $476K | Buy |
+152,638
| New | +$476K | ﹤0.01% | 902 |
|
|
2015
Q4 | – | Sell |
-4,185
| Closed | -$13K | – | 1420 |
|
|
2015
Q3 | $13K | Buy |
4,185
+3,635
| +661% | +$11.3K | ﹤0.01% | 1089 |
|
|
2015
Q2 | $2K | Buy |
+550
| New | +$2K | ﹤0.01% | 1313 |
|